ABCC1 and cancer: Overexpression of MRP1 was reported to confer multidrug resistance in acute leukemia, prostate cancer, breast cancer, and neuroblastoma by actively pumping out anti-cancer agents, thereby preventing the accumulation of anti-cancer drugs, eventually causing poor chemotherapeutic outcomes [10,22,23,24].